From the

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

PierianDx, the leading genomics technology companythat enables precision medicine,announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to […]

PierianDx Showcases Germline Capabilities of its Clinical Genomics WorkSpace™ (CGW) Platform at ACMG 2018

PierianDx, the leading genomics technology company that enables precision medicine, announced today at the annual meeting of the American College of Medical Genetics and Genomics (ACMG)  a series of enhanced germline […]

PierianDx Names Chris Callahan as Chief Commercial Officer to Drive Expansion of its Genomics Technology Platform for Clinical Labs

PierianDx named Chris Callahan as the new Chief Commercial Officer to accelerate adoption and expansion of the company’s enterprise informatics software platform, the Clinical Genomics WorkSpace (CGW). Chris will report […]

CMS Final Coverage Decision for NGS: a Victory for Lab Developed Tests and Cancer Patients

Learn more about the recent coverage decision and what it means for Laboratory Developed Tests and Cancer Patients.

PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution

PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for healthcare organizations, announced today a partnership with Cancer Genetics, Inc. (CGI) (Nasdaq: CGIX) to provide a […]